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Abstract : Ischemia/reperfusion (I/R) has been associated with ventricular (LV) remodeling, including induction of
hypertrophy. Stimulation of α
1
-Adrenoceptors (ARs) has been implicated in the pathogenesis of cardiac hypertro-
phy. The present study is to test the hypothesis that α
1
-AR-mediated hypertrophy is selectively mediated via the oxi-
dative modification of G
h
 during hypoxia/reoxygenation (H/R) or I/R. Reactive oxygen species (ROS) was increased
in H/R and expression level of membrane G
h
. To further address involvement of G
h
 in hypertrophic response, spe-
cific relation of G
h
 was confirmed by using G
h
 overexpression and blocking into cardiomyocytes. Mainly increased
membrane G
h
 protein by ROS has a more sensitive effect on myocardial hypertrophy through MEK1,2/ERKs signal
transduction pathway, but induction of proto-oncogene except c-fos and expression of PLC δ
1
 was independent in
ROS condition. These results provide that ROS production by I/R mediates G
h
 protein increment and G
h
 protein
leads to more specific responsiveness to NE-stimulated hypertrophic cardiomyocytes.
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1. Introduction
Ischemic condition is lead to reduce morbidity and mortality
when coronary blood supply to myocardium is decreased.
Oxygen supply is insufficient to support oxidative
phosphorylation of mitochondria, and may be followed by
reperfusion.
1
 Cardiac hypertrophy is a compensatory process
which occurs in pathological conditions and an adaptation
process against hemodynamic overload.
2
 Hypertrophy should
be result in wall thickness, reduction of ventricular lumen,
increment of cardiomyocyte length and ventricular luminal size
in the heart. The relationship between cardiac hypertrophy and
adrenergic activity been documented several reports.
3,4
Adrenoceptors (ARs), members of the G-protein coupled
receptor (GPCR), have an important role in interface between
sympathetic nerve and the cardiovascular system in the rapid
regulation of myocardial function.
5-7
 Among α-ARs, the α
1
-
ARs exist in cardiomyocytes and have been implicated in the
pathogenesis of cardiac hypertrophy in ischemia-induced
cardiac arrythmias and ischemic preconditioning.
8
 Signaling
pathways leading from α
1
-ARs activation to hypertrophy are
complex and may involve activation of extracellular signal-
regulated protein kinase (ERK) and PI3K through G
q
, PKC,
Ras, and activation of calcineurin through Ca
2+
 and
calmodulin.
9,10
G
h
 (tissue type transglutaminase2) is ubiquitously expressed
in mammalian tissues and acts as enzymatically-active
transglutaminases and GTP-binding protein mediating
intracellular signaling via the α
1B
-AR.
11
 Previous studies
indicate that G
h 
play a main regulator in cell growth and
differentiation, apoptosis and tissue repair as well as cardiac
hypertrophy by α
1
-AR stimulation,
12,13
 and participate in the
AR signaling pathway to ischemia/reperfusion (I/R) by using
knockout mice.
14
 Reactive oxygen species (ROS) such as
superoxide generated endogenously or in response to
environmental stress has been implicated in tissue injury
including I/R. Several researchers have shown that ROS could
†
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link to the hypertrophy in neonatal rat ventricular myocytes as
well as in adult rat ventricular myocytes
15,16
 and may mediate
α-AR-stimulated hypertrophic signaling in adult myocytes via
G protein modification.
17
 Yet, hypertrophic molecular
mechanism of G
h 
activation induced by ROS in exact I/R heart
remains poorly understood.
In the present study, it will be addressed whether production
of ROS through I/R or hypoxia/reoxygenation (H/R) injury
affect oxidative modification of G
h
 and lead to NE-stimulated
hypertrophy. Here, our data showed that α
1
-AR-mediated
hypertrophic responses was related to G
h
 and overexpressed or
downregulated G
h
 regulated to ERK1,2 signal. In addition, I/R
or H/R affected to MEK1,2/ERK1,2 signal transduction
pathway, while PLC δ
1
 and proto-oncogene was independent
on NE-stimulated cardiomyocytes.
2. Materials and Methods
2.1 Myocardial Ischemia-Reperfusion Injury
All experimental procedures for animal studies were
approved by the Committee for the Care and Use of Laboratory
Animals, Yonsei University College of Medicine and were
performed in accordance with the Committee's Guidelines and
Regulations for Animal Care. Myocardial infarction was
produced in male Sprague-Dawley rats (200±50 g) by surgical
occlusion of left anterior descending coronary artery, according
to the method described previously with minor modifications.
18
Briefly, rats were anesthetized by intramuscular injection of
zoletil (50 mg/kg) and xylazine (5 mg/kg), and the chest was
opened by cutting the third and fourth ribs. The heart was
exteriorized through the intercostal space and the left coronary
artery was ligated 2-3 mm from its origin with a 6-0 prolene
suture. Coronary occlusion was maintained for 1 h, followed by
removal of the suture and reperfusion for 3 h. Throughout the
operation, the animals were ventilated with 95% O
2
 and 5%
CO
2
, using a Harvard ventilator (Harvard Apparatus, USA).
Sham-operated animals were treated similarly, except that the
coronary suture was not tied.
2.2 Culture of Cardiomyocytes and In Vitro Hypoxia-
Reoxygenation Treatment
Neonatal rat cardiomyocytes were prepared by an enzymatic
method. Briefly, hearts of 1- to 2-day-old Sprague-Dawley rat
pups were dissected, minced, enzymatically dispersed with 10
ml of collagenase I (0.8 mg/ml, 262 U/mg, Gibco BRL, UK)
and centrifuged differentially to yield 5×10
5
 cells/ml. After
incubation for 4-6 h, the cells were rinsed twice with cell culture
medium and 0.1 mM BrdU (Sigma Chemical, USA) was
added. Cells were then cultured in a CO
2
 incubator at 37
o
C for
1-2 days. For the treatment of H/R, the cells were incubated for
1 h using deoxygenated serum free α-MEM in an anaerobic
chamber (Thermo Forma, USA).
2.3 Measurement of Intracellular Reactive Oxygen
Species Generation
Cardiomyocytes were labeled with 10 µM 2' ,7' -
dichlorodihydrofluorescein diacetate (H
2
DCFDA; Invitrogen
Co., USA). The dye, when exposed to an excitation wavelength
of 480 nm, emits light at 535 nm only when it has been
oxidized. Labeled cells were examined using a luminescence
spectrophotometer for oxidized dye.
2.4 Flow Cytometry
Cardiomyocytes were retrieved with a standard trypsiniza-
tion technique. Cells were washed in phosphate buffered saline
(PBS) and fixed in 70% ethanol at 4
o
C for 30 min with
agitation. Cells were washed twice in PBS and resuspended at
2×10
6 
cells/ml in blocking buffer (1% BSA, 0.1% FBS)
containing anti-G
h
 antibody (Santa Cruz Biotechnology, USA)
diluted at 1/200. The labeling reaction mixture was agitated for
20 min at room temperature. Cells were washed twice and then
labeled with anti-goat-FITC conjugated IgG (Jackson
ImmunoResearch Laboratories, USA) diluted to 1/400 for 20
min at room temperature in the dark. After two more washes,
flow cytometric analysis was performed on FACS Calibur
system (Becton Dickinson, USA) using CellQuest™ software
with 10,000 events recorded for each sample. Data was
acquired in single parameter histogram with appropriate
particlesize and light scatter gating.
2.5 Transfection
Transfections of G
h
 cloned into pcDNA3.1 (Invitrogen) were
performed using LIPOFECTAMINE PLUS™ reagent
(Invitrogen). Briefly, cardiomyocytes cultured in a 60 mm
culture plate (5×10
5
 cells/plate) were washed twice with serum-
free MEM. LIPOFECTAMINE PLUS™ reagent was diluted
with serum-free MEM and combined with 2 µg of DNA for
each plate. The DNA and LIPOFECTAMINE PLUS™
complexes were added onto each plate. After 12 h incubation in
a CO
2
 incubator at 37
o
C, the medium was changed to 10%
FBS-MEM.
2.6 RNA Interference
For function-blocking experiments, we used small
interfering RNA molecules (siRNA) targeted at G
h
 mRNA. A
2l-nt sequence for siRNA was derived from the rat G
h
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(GenBank accession no. GI: 9507184) and obtained from
Ambion (USA): siRNA sequence of G
h
 (sense: 5’-
GGGUUACCGGAAUAUCAUCTT-3’ antisense: 5’-
GAUGAUAUUCCGGUAACCCTT-3’). Cardiomyocytes were
transfected with siRNA by using siPORT NeoFX (Ambion).
Briefly, RNA duplex (10 nM of final concentration) was
incubated in serum-free α-MEM containing 15 µl of siPORT
NeoFX for 10 min. The complex was added to the empty 60
mm culture plate, then overlay cardiomyocytes suspension (1
×10
5
 cells/plate) onto the culture plate wells containing
transfection complexes. The transfected cells were incubated in
normal cell culture condition until ready for assay.
2.7 Immunoblot Analysis
Proteins were separated by SDS-PAGE using 10-12%
polyacrylamide gels and then electrotransferred to methanol-
treated polyvinylidene difluoride (PVDF) membranes. The
blotted membranes were washed twice with water and blocked
by incubation with 5% nonfat dried milk in PBS buffer (8.0 g
NaCl, 0.2 g KCl, 1.5 g NaH
2
PO
4
, 0.2 g K
2
HPO
4
 per liter). The
membranes were probed with G
h
, G
q
, G
s
, ERK1/2, MEK, PLC-
δ1, β-actin, anti-phospho-p38 kinase, -JNK, -ERK1/2 and -
MEK antibodies (Santa Cruz Biotechnology), followed by goat
anti-rabbit, goat anti-mouse and mouse anti-goat IgG-
peroxidase. The blots were detected using enhanced
chemiluminescence kits (ECL; GE healthcare, USA).
2.8 RT-PCR Analysis
The mRNA level of proto-oncogene was analyzed by the
reverse transcription polymerase chain reaction (RT-PCR)
technique. Total RNA was prepared by Ultraspect™-II RNA
system (Biotecx Laboratories, USA), and single-stranded cDNA
was then synthesized from isolated total RNA by Avian
myeloblastosis virus (AMV) reverse transcriptase. A 20-µl
reverse transcription reaction mixture containing 1 µg of total
RNA, 1× reverse transcription buffer (10 mM Tris–HCl, pH 9.0,
50 mM KCl, 0.1% Triton X-100), 1 mM deoxynucleoside
triphosphates (dNTPs) 0.5 unit of RNase inhibitor, 0.5 µg of
oligo(dT)
15
, and 15 units of AMV reverse transcriptase were
incubated at 42
o
C for 15 min, heated at 99
o
C for 5  min, and then
incubated at 0-5
o
C for 5 min. PCRs were performed for 35 cycles
with 3’ and 5’ primers based on the sequences of proto-oncogene
primers (c-jun: 5’-AACGACCTTCTACGACGATG-3’ and 5’-
GCAGCGTATTCTGGCTATGC-3’ c-myc: 5’-GTCACGA
CGATGCCCCTCAACGTG-3’ and 5’-AAGTCCAAGTT
CTGTCAGAAGGAA-3’ c-fos: 5’-ACCATGATGTTCT
CGGGTTTCAAC-3’ and 5’-CTCTGTAATGCACCAGCTCA
GTCA-3’). The GAPDH primers (5’-CTCCC AACGTGTCTG
TTGTG-3’ and 5’-TGAGCTTGACAAAGTGGTCG-3’) were
used as the internal standard. The signal intensity of the
amplification product was normalized to its respective GADPH
signal intensity.
2.9 Confocal Microscopy and Fluorescence Measurements
The measurement of cytosolic free Ca
2+
 concentration was
es t imated by the  confoca l  m icroscopy analys i s .
Cardiomyocytes are plated on 4-well slide coated with 1.5%
gelatin for 1 day in α-MEM containing 10% fetal bovine serum
(Invitrogen) and 0.1 µM BrdU (Sigma Chemical). After
incubation, the cells were washed with modified Tyrode's
solution with 0.265 g/l CaCl
2
, 0.214 g/l MgCl
2
, 0.2 g/l KCl,
8.0 g/l NaCl, 1 g/l glucose, 0.05 g/l NaH
2
PO
4
 and 1.0 g/l
NaHCO
3
.Werethen loaded with 5 mM of the acetoxymethyl
ester of fluo-4 (Fluo-4 AM, Invitrogen) for 20 min, in the dark
and at 37
o
C. Fluorescence images were collected using a
confocal microscope (Leica, Germany) excited by 488 nm line
of argon laser and emitted light collected through a 510-560 nm
band-pass filter. Relative data of intracellular Ca
2+
 was
determined by measuring fluorescent intensity.
2.10 Statistical Analysis
Data were summarized from 3 individual experiments and
expressed as means±S.E. Statistical analyses were performed
by one-way ANOVA, using Bonferroni test for comparison of
several groups. A value of P<0.05 was considered significant.
3. Results
3.1 ROS Production in H/R Cardiomyocytes
To show the ROS production in H/R cardiomyocytes as
compared with I/R myocardium, ROS production was
monitored at  different  t imes of  reoxygenat ion in
cardiomyocytes. And exogenously added H
2
O
2 
was chosen as
positive control to show an increase in intracellular ROS. H (1
h) / R (3 h) caused a marginal increase in DCF fluorescence
over the labeled normoxic control and hypoxic control cells.
These data indicate that H (1 h) / R (3 h) condition expresses to
meaningful ROS production (Fig 1A). In positive control, ROS
production was significantly increased in H
2
O
2
 (200 µM)
treatment for 30 min (Fig 1B).
3.2 Expression of G Proteins in H/R Cardiomyocytes
and I/R Myocardium
It has been known that alteration of G proteins is related with
adrenergic receptor. We were preliminarily examined that
expression level of α
1
-adrenoceptor was the highest in both H/
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R cardiomyocytes and I/R myocardium among many subtypes
of adrenoceptor (data not shown). To find whether the changes
of G protein expression levels were involved with hypertrophy
in H/R and I/R, expression level of the G proteins was
examined. In H/R cardiomyocytes, G
h 
protein expression was
mainly increased but the other G proteins expression were not
hardly changed, compared to normal cardiomyocytes (Fig 2A).
To address these phenomena in vivo, expression levels of G
proteins were also measured in I (1 h) / R (3 h) myocardium.
Like H/R cardiomyocytes, expression of G
h
 was significantly
increased but the other G proteins was not changed in I/R
myocardium (Fig 2B). Furthermore, G
h 
protein translocated in
cellular membrane was more increased than cytosolic G protein
after H (1 h) / R (3 h) (Fig 2C). Also increment of G
h 
protein by
reoxygenation was time-dependently confirmed (Fig 2D).
3.3 Selectivity of G Protein in NE-Stimulated H/R
Cardiomyocytes
Our previous study showed that G
h
 is partially involved in
α
1
-adrenergic receptor-stimulated cardiac hypertrophy
independent of G
q
 regulation.
19
 To further address the
involvement of G
h
 in hypertrophic response of NE-treated
Figure 1. Reactive oxygen species (ROS) production in hypoxia/reoxygenated cardiomyocytes. (A) Neonatal cardiomyoctes subjected to
hypoxia at reoxygenation time-dependent manner. ROS production was detected by fluorescence of H
2
DCFDA (10 µM). (B) H
2
O
2
(200 µM) was added in cardiomyocytes (*p < 0.01).
Figure 2. Expression of G proteins in H/R cardiomyocytes and I/R myocardium. Cardiomyocytes obtained from H (1 h) / R (3 h) (A) and
heart tissues obtained from I (1 h) / R (3 h) (B) were performed Western blot analysis for expression of G proteins. (C) Expression levels
of membrane and cytosolic G
h 
were also estimated in immunoblot analysis. (D) Expression level of G
h 
in H (1 h) /R (0 h, 1 h, and 3 h)
cardiomyocytes was obtained in flow cytometry. (a) normal control, (b) H 1 h, (c) H 1 h/R 1 h, (d) H 1 h/R 3 h, and (e) Expression level
of G
h
 (*p < 0.01 and **p < 0.001). 
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cardiomyocytes, G
h
 gene was transfected into cardiomyocytes
for overexpression. In G
h
-transfected cells, G
h
 protein was
highly expressed both in membrane and in cytosolic fraction
(Fig 3A). NE further was increased phosphorylation of ERKs
about 1.7-fold compared to the only NE-treated cell. To test if
the increased phosphorylation of ERKs tightly relates to G
h
overexpression in NE-stimulated cardiomyocytes, siRNA for
G
h 
was transfected into cells for transient knock down of G
h
. In
cells treated with siRNA for G
h
, NE-stimulated cardiomyocytes
abolished phosphorylation of ERKs induced by α
1
-AR (Fig
3B). These data indicate that H/R stimulation and I/R injury
affect the expression of G
h
, leading to ERKs phosphorylation.
3.4 Effect of MAPK Subfamily in NE-Stimulated H/R
Cardiomyocytes
To test if overexpression of G
h
 induced by H/R affects
MAPK pathway, expression and phosphorylation level of
MAPK subfamily was examined in H (1 h) / R (3 h). As shown
in previous data, increased G
h
 protein inducing H/R affected
more highly on the hypertrophic marker MAPKs by NE
stimulation in cardiomyocytes. The phosphorylation of ERKs,
not p38 and JNK, was up-regulated by the treatment with H/R
and NE (10 min) treatment, compared with NE-treated cells
(Fig 3C). The phosphorylation of MEK1,2, upstream regulator
of ERKs, was significantly increased in H (1 h) / R (3 h) (Fig
3D). These results show that intracellular signaling pathway
induced by NE primarily processes by MEK1,2/ERKs cascade
through α
1
-AR in cardiomyocytes, and MEK1,2/ERKs
cascade mediates to G
h
 protein increment through H/R.
3.5 Regulation of Proto-Oncogene Expression in H/R
Cardiomyocytes
To determine the immediate-early response oncogenes in
hypertrophy via H/R, we examined the mRNAs for c-jun, c-fos,
Figure 3. Changes between G
h
 and MAPK signaling pathway in the H/R cardiomyocytes. Cardiomyocytes were treated siRNA for 12 h
and/or transfected pMT/G
h
 for additional 12 h and then NE stimulation was added for 10 min. G
h
 expression in membrane, cytosol, and
total protein (A) and ERK phosphorylation (B) were detected by immunoblot analysis. (C) Activation of ERK, JNK and P38 was
assessed under H (1 h) /R (3 h) with or without NE (10 µM) stimulation. (D) Cardiomyocytes were exposed to 1 h hypoxia followed by
1 h and 3 h reoxygenation. Phosphorylation of MEK1,2 was also detected by Western blot analysis (*p < 0.01).
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and c-myc in H/R cardiomyocytes. Significant increases in c-
jun, c-fos and c-myc were observed by NE stimulation or H/R,
but only c-fos was significantly elevated by H/R with additional
NE treatment (Fig 4A). The mRNA levels of c-jun and c-myc
were the independent consequence, the level of c-fos mRNA
was increased after H/R and NE. It seems that c-jun and c-myc
do not have involvement in hypertrophic response by oxidative
modification of G protein. These data show that increased
expression level of G
h
 in H/R mainly affects c-fos and
activation of c-fos maybe provoke myocardial hypertrophy.
3.3 Expression of G Proteins on PLC-δ
1
 in H/R Cardio
myocytes and I/R Myocardium
We previously examined that PLC-δ
1
 is the effector of G
h
-
mediated signaling. As the enzymatic activity of all PLC
isozymes is dependent on Ca
2+
 concentration, the increment of
intracellular Ca
2+
 may contribute to the increase in PLC-δ
1
expression.
20
 But PLC-δ
1 
was decreased in H (1 h)/R (3 h) and
I (1 h)/ R(3 h) and did not coincide with elevated G
h 
protein (Fig
4B). Enhanced expression level of G
h
 by H/R or I/R was
influenced by ROS production and not by increased
intracellular Ca
2+ 
concentration. These results mean that this
hypertrophic mechanism involved in H/R and I/R was
independent from pathway related to PLC δ
1.
4. Discussion
Cardiac hypertrophy is an essential process due to
hemodynamic overload. Growth of hypertrophy is caused by
increased workload, and NE, the primary transmitter of the
sympathetic nervous system inducer, induces hypertrophy in
numerous tissues including heart via interaction with GPCR to
adrenoceptor and phospholipase C (PLC) and G
q
 protein
mediates hypertrophic response in heart.
4,21
 But, we and some
groups have recently proposed that cardiac hypertrophy also
related to the G
h
 pathway by α
1
-AR stimulation.
19,22
In this study, we identified that α
1
-AR-mediated hypertrophy
is more selectively mediated via the oxidative modification of
Figure 4. Specific regulation in proto-oncogene and PLC-δ1 expression in H/R cardiomyocytes. (A) The mRNA expression in cardi-
omyocytes was evaluated by RT-PCR analysis. Cardiomyocytes were 10 min stimulation with NE after H (1 h) / R (3 h). (B) Cardiomy-
ocytes and heart tissues were each obtained from H (1 h) / R (3 h) and I (1 h) / R (3 h). Phosphorylation of PLC-δ1 was detected
immunoblot analysis. (C) Cardiomyocytes were exposed to H (1 h)/ R (3 h) and representative [Ca
2+
]
i
 images were presented with fluo-
4 fluorescence (
#
p < 0.05 and *p < 0.01).
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G
h
 during H/R or I/R injury. First of all, we primarily confirmed
that mRNA levels of α
1
-adrenoceptor subtype in H/R condition
were not different and expressions of α
1A
, a
1B
 and a
1D
 were not
changed in I/R myocardium in vivo level (data not shown).
These data indicate that hypertrophic response by ROS
production was not related to the expression of α
1
-AR each
subtypes in both H/R cardiomyocytes and I/R myocardium.
Because of acute myocardial infarction, heart undergoes
ischemic heart disease, and that is a major cause of mortality
and morbidity. While reperfusion of ischemic myocardium is
pivotal situation in myocardial salvage, reperfusion may also
result in myocardial damage, according to cell swelling and
disruption of mitochondrial membrane.
23
 These mechanisms
have included below. 1) cellular calcium loading, 2) no reflow
phenomenon, and 3) oxygen radicals. Most importantly, ROS,
unformation of oxygen radicals, is generated in ischemia and
subsequent reperfusion. Isolated cardiomyocytes have
experimented that hypoxia increases ROS production and
damage of electron transport complexes.
24
 While low levels of
oxygen radicals importantly play in cellular homeostasis,
differentiation and signaling.
25
 Some studies demonstrated that
receptor-stimulated coupling of the α
1A
-adrenergic receptor to
Gα
q/11
 protein was increased in the tail arteries subjected to I/R.
26
Therefore, we also demonstrated in neonatal cardiomyocytes that
α-AR-stimulated hypertrophy is associated with ROS-mediated
activiation of G
h
. The expression level of G
h
 was increased
through ROS production, and increased G
h
 affects the
development of myocardial hypertrophy in H/R (Fig 2 and 3).
And, we examined the signaling pathway on hypertrophy by
G
h
 modification. After the exposure of the neonatal
cardiomyocytes to I/R, NE stimulation leads to enhanced α
1
-
adrenergic-receptor-stimulated hypertrophy through enhanced
G
h
-MEK1,2-ERKs signaling and expression of c-fos (Fig 4A).
During growth of cardiac hypertrophy, heart has been observed
specific changes, 1) rapid induction of proto-oncogenes and
heat shock protein genes (immediate-early genes), 2)
quantitative and qualitative changes in gene expression, and 3)
increased rate of protein synthesis.
2
 The c-fos mediates both
proliferative and cellular growth in many cell types. Recently,
some researcher argued that the expression of c-fos was
increased after I/R in brain tissue, also increased by hepatic I/R
in rats, and stimulated by activation of PKC and this was related
to increase of skeletal α-actin genes, β-MHC and MLC-2a
which increase in hypertrophic response.
27-29
 These results
indicated that myocardial hypertrophy may involve in the early
phase of myocardial H/R.
The hypertrophic signaling pathway via PLC was examined
by many researchers. Some reports demonstrated that increased
PLC-β
1
 and -γ
1 
activities during cardiac hypertrophic response
and decreased PLC-γ
1
 and -δ
1
 activities during heart failure
suggested an important action of PLC isozymes by volume
overload of heart.
30
 Hypertrophic response may be related to
α
1
/Gqa/PLC-β
1
 signaling pathway.
31
 The data in the study
provide that hypertrophic mechanism related with G
h
was
independent from pathway related to PLC-δ
1 
(Fig 4B and 4C)
.
Thus, we revealed that PLC-δ
1 
has no relation in hypertrophy
via ROS modification of G
h
.
Taken together, these findings indicate that α
1
-AR
stimulation by ROS cause the oxidative posttranslational
modification of G
h 
in neonatal cardiomyocytes. Increased G
h
enhanced hypertrophic response through the MEK1,2-ERKs
signaling and c-fos expression. Thus, modification of G
h
 by
ROS may play a role in the pathophysiology and/or therapy of
myocardial remodeling.
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